Pharmacokinetic analysis of nicotine and its metabolites (cotinine and trans-3'-hydroxycotinine) in male Sprague-Dawley rats following nose-only inhalation, oral gavage, and intravenous infusion of nicotine.

Autor: Tang Y; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Bryant MS; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Li M; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Min S; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Pellar G; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Wu Q; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Yang DJ; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Kang HK; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Sepehr E; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., He X; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., McLellen F; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Lewis SM; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Greenhaw J; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Fisher J; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Yang X; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Chemerynski S; Center for Tobacco Products (CTP), FDA, Silver Spring, MD 20993, United States., Yee SB; Center for Tobacco Products (CTP), FDA, Silver Spring, MD 20993, United States., Rosenfeldt H; Center for Tobacco Products (CTP), FDA, Silver Spring, MD 20993, United States., Yeager RP; Center for Tobacco Products (CTP), FDA, Silver Spring, MD 20993, United States., Howard PC; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Hu SC; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States., Roqué P; Center for Tobacco Products (CTP), FDA, Silver Spring, MD 20993, United States., Goel R; Center for Tobacco Products (CTP), FDA, Silver Spring, MD 20993, United States., Kc P; Center for Tobacco Products (CTP), FDA, Silver Spring, MD 20993, United States., Yi J; National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA), Jefferson, AR 72079, United States.

Publikováno v: Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2024 Dec 01; Vol. 202 (2), pp. 196-209.

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model.

Autor: Inselman AL; Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Masters EA; Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Moore JN; Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Agarwal R; Office of New Drug Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States., Gassman A; Division of Urology, Obstetrics and Gynecology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States., Kuijpers G; Division of Urology, Obstetrics and Gynecology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States., Beger RD; Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Delclos KB; Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Swift S; Office of Dietary Supplement Program, Center for Food Safety and Nutrition, U.S. Food and Drug Administration, College Park, MD, United States., Camacho L; Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Vanlandingham MM; Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Sloper D; Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Nakamura N; Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Gamboa da Costa G; Office of the Center Director, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Woodling K; Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Bryant M; Office of Scientific Coordination, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Trbojevich R; Office of Scientific Coordination, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Wu Q; Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., McLellen F; Office of Scientific Coordination, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, United States., Christner D; Office of New Drug Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2024 Apr 16; Vol. 15, pp. 1365151. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).

Evaluating endocrine disrupting chemicals: A perspective on the novel assessments in CLARITY‐BPA.

Autor: Howdeshell, Kembra L., Beverly, Brandiese E. J., Blain, Robyn B., Goldstone, Alexandra E., Hartman, Pamela A., Lemeris, Courtney R., Newbold, Retha R., Rooney, Andrew A., Bucher, John R.

Publikováno v: Birth Defects Research; Sep2023, Vol. 115 Issue 15, p1345-1397, 53p

Information and communication technology (ICT) in oncology. Patients' and relatives' experiences and suggestions.

Autor: Jan Norum, Anne Grev, Mari-Ann Moen, Lise Balteskard, Kari Holthe

Publikováno v: Supportive Care in Cancer; May2003, Vol. 11 Issue 5, p286-293, 8p